Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Current Assets (2020 - 2025)

Treace Medical Concepts (TMCI) has disclosed Current Assets for 6 consecutive years, with $132.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Assets fell 18.18% year-over-year to $132.1 million, compared with a TTM value of $132.1 million through Dec 2025, down 18.18%, and an annual FY2025 reading of $132.1 million, down 18.18% over the prior year.
  • Current Assets was $132.1 million for Q4 2025 at Treace Medical Concepts, down from $138.0 million in the prior quarter.
  • Across five years, Current Assets topped out at $223.1 million in Q1 2023 and bottomed at $36.5 million in Q1 2021.
  • Average Current Assets over 5 years is $151.3 million, with a median of $144.2 million recorded in 2021.
  • The sharpest move saw Current Assets soared 249.25% in 2022, then fell 20.26% in 2025.
  • Year by year, Current Assets stood at $138.0 million in 2021, then fell by 3.31% to $133.4 million in 2022, then surged by 48.69% to $198.4 million in 2023, then fell by 18.63% to $161.4 million in 2024, then fell by 18.18% to $132.1 million in 2025.
  • Business Quant data shows Current Assets for TMCI at $132.1 million in Q4 2025, $138.0 million in Q3 2025, and $147.6 million in Q2 2025.